X
X
Total 393357 Results
| Label | Description | ILX | Version | Created CID | Modified Time | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Beam Number | Identification number of the Beam. The value of Beam Number (300A,00C0) shall be unique within the RT Plan in which it is created. | ILX:0101154 | 4 | scicrunch | 06/18/2018 | scicrunch | term | 12/08/2016 | 0 | NeuroLex | NeuroLex |
| Beam Sequence | Introduces sequence of treatment beams for current RT Plan. One or more items may be included in this sequence. | ILX:0101155 | 4 | scicrunch | 06/18/2018 | scicrunch | term | 12/08/2016 | 0 | NeuroLex | NeuroLex |
| Beam Stopper Position | Position of Beam Stopper during beam administration. | ILX:0101156 | 4 | scicrunch | 06/18/2018 | scicrunch | term | 12/08/2016 | 0 | NeuroLex | NeuroLex |
| Beam Type | Motion characteristic of Beam. | ILX:0101157 | 4 | scicrunch | 06/18/2018 | scicrunch | term | 12/08/2016 | 0 | NeuroLex | NeuroLex |
| Beat Rejection Flag | Beat length sorting has been applied. | ILX:0101158 | 4 | scicrunch | 06/18/2018 | scicrunch | term | 12/08/2016 | 0 | NeuroLex | NeuroLex |
| Becaplermin | Becaplermin is produced by recombinant DNA technology by insertion of the gene for the B chain of platelet derived growth factor (PDGF) into the yeast, Saccharomyces cerevisiae. Becaplermin has a molecular weight of approximately 25 KD and is a homodimer composed of two identical polypeptide chains that are bound together by disulfide bonds Pharmacology: Used for the topical treatment of skin ulcers, Regranex has a biological activity similar to that of endogenous platelet-derived growth factor, which includes promoting the chemotactic recruitment and proliferation of cells involved in wound repair and enhancing the formation of granulation tissue. Mechanism of action: Binds to the beta platelet-derived growth factor (PDGF) receptor, a tyrosine kinase receptor. PDGF is known to exist as a dimer, and activates its signaling pathway by a ligand induced receptor dimerization and autophosphorylation. PDGF receptors also contain many auto-phosphorylation sites, which serve to mediate binding of SH2 sites and subsequently signal corresponding pathways. There are five different isoforms of PDGF that activate through two different receptors (alpha and beta). Drug type: Approved. Biotech. Investigational. Drug category: Anti-Ulcer Agents. Topical | ILX:0101159 | 3 | scicrunch | 06/18/2018 | scicrunch | term | 12/08/2016 | 0 | NeuroLex | NeuroLex |
| Beck Depression Inventory | Beck Depression Inventory (or BDI) is a 21-question self assessment used to measure the severity of a patient's depression. There are three versions of BDI released in 1961, 1978, and 1996. A survey is completed by a patient, with each answer scored on a scale of 0 to 3, designed to measure presence of depression. (NCI). | ILX:0101160 | 7 | scicrunch | 08/24/2018 | scicrunch | term | 12/08/2016 | 0 | NeuroLex | troy sincomb |
| Becker Muscular Dystrophy | ILX:0101161 | 3 | scicrunch | 06/18/2018 | scicrunch | term | 12/08/2016 | 0 | NeuroLex | NeuroLex | |
| Beclomethasone | An anti-inflammatory, synthetic glucocorticoid. It is used topically as an anti-inflammatory agent and in aerosol form for the treatment of asthma. (PubChem) Pharmacology: Beclomethasone, a synthetic halogenated glucocorticoid with antiinflammatory and vasoconstrictive effects, is used for treating steroid-dependent asthma, allergic or nonallergic rhinitis, or recurrent nasal polyps. Mechanism of action: Unbound corticosteroids cross cell membranes and bind with high affinity to specific cytoplasmic receptors. The result includes inhibition of leukocyte infiltration at the site of inflammation, interference in the function of mediators of inflammatory response, suppression of humoral immune responses, and reduction in edema or scar tissue. The antiinflammatory actions of corticosteroids are thought to involve phospholipase A2 inhibitory proteins, lipocortins, which control the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes. Drug type: Approved. Small Molecule. Drug category: Anti-Asthmatic Agents. Anti-inflammatory Agents. Antiarrhythmic Agents. Corticosteroids. Glucocorticoids | ILX:0101162 | 3 | scicrunch | 06/18/2018 | scicrunch | term | 12/08/2016 | 0 | NeuroLex | NeuroLex |
| Bed nuclei of the stria terminalis anterior division anterolateral area of ABA 2009 | ILX:0101163 | 3 | scicrunch | 06/18/2018 | scicrunch | term | 12/08/2016 | 0 | NeuroLex | NeuroLex | |
| Bed nuclei of the stria terminalis anterior division dorsomedial nucleus of ABA 2009 | ILX:0101164 | 3 | scicrunch | 06/18/2018 | scicrunch | term | 12/08/2016 | 0 | NeuroLex | NeuroLex | |
| Bed nuclei of the stria terminalis anterior division fusiform nucleus of ABA 2009 | ILX:0101165 | 3 | scicrunch | 06/18/2018 | scicrunch | term | 12/08/2016 | 0 | NeuroLex | NeuroLex | |
| Bed nuclei of the stria terminalis anterior division juxtacapsular nucleus of ABA 2009 | ILX:0101166 | 3 | scicrunch | 06/18/2018 | scicrunch | term | 12/08/2016 | 0 | NeuroLex | NeuroLex | |
| Bed nuclei of the stria terminalis anterior division magnocellular nucleus of ABA 2009 | ILX:0101167 | 3 | scicrunch | 06/18/2018 | scicrunch | term | 12/08/2016 | 0 | NeuroLex | NeuroLex | |
| Bed nuclei of the stria terminalis anterior division of ABA 2009 | ILX:0101168 | 3 | scicrunch | 06/18/2018 | scicrunch | term | 12/08/2016 | 0 | NeuroLex | NeuroLex | |
| Bed nuclei of the stria terminalis anterior division oval nucleus of ABA 2009 | ILX:0101169 | 3 | scicrunch | 06/18/2018 | scicrunch | term | 12/08/2016 | 0 | NeuroLex | NeuroLex | |
| Bed nuclei of the stria terminalis anterior division rhomboid nucleus of ABA 2009 | ILX:0101170 | 3 | scicrunch | 06/18/2018 | scicrunch | term | 12/08/2016 | 0 | NeuroLex | NeuroLex | |
| Bed nuclei of the stria terminalis anterior division ventral nucleus of ABA 2009 | ILX:0101171 | 3 | scicrunch | 06/18/2018 | scicrunch | term | 12/08/2016 | 0 | NeuroLex | NeuroLex | |
| Bed nuclei of the stria terminalis of ABA 2009 | ILX:0101172 | 3 | scicrunch | 06/18/2018 | scicrunch | term | 12/08/2016 | 0 | NeuroLex | NeuroLex | |
| Bed nuclei of the stria terminalis oval nucleus | Part of bed nucleus of stria terminalis, comprising a distinct, large, egg-shaped collection of neurons that, together with the juxtacapsular (Ju) and rhomboid (Rh) nuclei, encompass the anterolateral area of the BST (Ju and Swanson, 1989) | ILX:0101173 | 5 | scicrunch | 06/23/2020 | scicrunch | term | 12/08/2016 | 0 | NeuroLex | NeuroLex |
About
Base community for the SciCrunch.org infrastructure
Contact Us
X